Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Post by icecubeon Jun 16, 2015 1:56pm

102 Views

Post# 23836175

Head and Shoulders Top?

TD Direct Investing

The Daily Bull & Bear Report

Daily Bull & Bear Report June 15, 2015

This daily report provides you with today's trade ideas based on the chart patterns that are automatically detected by Recognia ...

Cipher Partmaceuticals Inc. CPH (TSX)

Head and Shoulders Top

Trading closed at $10.92 to confirm a Long-Term Bearish Head and Shoulders Top pattern.

Bearish Event

83% move possible

Bullboard Posts

Canadian psychedelic stock to supply MDMA to Yale